ARCT Arcturus Therapeutics Ltd.

Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.

$37.03  -0.64 (-1.70%)
As of 04/09/2021 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/22/2013
Outstanding shares:  26,280,275
Average volume:  601,243
Market cap:   $972,370,175
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03969T109
ISIN:        US03969T1097
Sedol:      BKC9SX3
Valuation   (See tab for details)
PE ratio:   -13.48
PB ratio:   2.44
PS ratio:   101.94
Return on equity:   -18.19%
Net income %:   -756.35%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy